MedTrace Logo

Safety of Norepinephrine Administered Through Peripheral Venous Catheter

NCT03695445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1004

Last updated 2022-12-09

No results posted yet for this study

Summary

Norepinephrine is a drug that elevates the blood pressure. It is routinely administered through peripheral catheters during surgery. There is a risk of tissue damage in case of leakage of Norepinephrine from the catheter to the surrounding tissue. Another risk is irregular administration of Norepinephrine due to kinking of the peripheral catheter. This could lead to fluctuations in blood pressure. The primary aim of the study is to investigate complications from Norepinephrine administered in peripheral venous catheters. The secondary aim is to investigate if comorbidity, placement of the peripheral catheter or the duration of the infusion are associated with a higher rate of complications. 1000 patients will be included. Inclusion criteria: Patients who will undergo surgery with need for vasopressor support. Exclusion criteria: The patient has a central venous catheter, a peripherally inserted central venous catheter or lack of informed consent.

Conditions

Interventions

DRUG

Peripheral administration of Norepinephrine

Systematic follow-up of complications from peripheral administration of Norepinephrine

Sponsors & Collaborators

  • Christer Svensen

    lead OTHER

Principal Investigators

  • Elisabeth Andersson, MD · Stockholm South General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2022-04-04
Completion
2022-04-06
FDA Drug
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695445 on ClinicalTrials.gov